Tsai I.-C.TUN-JUN TSAI2020-12-242020-12-2420091016-7390https://www.scopus.com/inward/record.uri?eid=2-s2.0-67749113461&partnerID=40&md5=49849484bf9ce2f087ebb6d4ec17150ehttps://scholars.lib.ntu.edu.tw/handle/123456789/532326Hypertensive kidney disease is one of the most common cause of end stage renal disease. Hypertension is also the most common complication of chronic kidney disease. Chronic hypertension makes the vessels of kidney become sclerotic and further deteriorate renal function. Factors that correlate with the progression of hypertensive kidney disease include blood pressure control, the severity of proteinuria, renal function, hyperlipidemia, races and genes, etc. The most effective medications for hypertensive kidney disease are angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. However, physicians should monitor renal function and serum potassium cautiously to decrease the risk of complications.[SDGs]SDG3aldosterone antagonist; amlodipine; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; hydralazine; loop diuretic agent; losartan; metoprolol; potassium; ramipril; article; blood pressure regulation; chronic disease; chronic kidney disease; deterioration; disease severity; heredity; human; hyperlipidemia; kidney blood vessel; kidney failure; kidney function; kidney ischemia; nephrosclerosis; patient monitoring; potassium blood level; proteinuria; renin angiotensin aldosterone system; renovascular hypertension; risk reduction; sclerosisjournal article2-s2.0-67749113461